100 medicines held by Merck Sharp & Dohme BV on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Bridion 100 mg/ml solution for injection EU/1/08/466/1-2 |
Sugammadex | Merck Sharp & Dohme BV | — |
| Cancidas 50 mg powder for concentrate for solution for infusion EU/1/01/196/001 |
Caspofungin | Merck Sharp & Dohme BV | — |
| Cancidas 70 mg powder for concentrate for solution for infusion EU/1/01/196/003 |
Caspofungin | Merck Sharp & Dohme BV | — |
| CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent) EU/1/25/1913/001-006 |
Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197, Pneumococcal polysaccharide serotype 7F conjugated to CRM197, Pneumococcal polysaccharide serotype 8 conjugated to CRM197, Pneumococcal polysaccharide serotype 9N conjugated to CRM197 | Merck Sharp & Dohme BV, | — |
| Cubicin 350 mg powder for solution for injection or infusion EU/1/05/328/001 |
Daptomycin | Merck Sharp & Dohme BV | — |
| Cubicin 500 mg powder for solution for injection or infusion EU/1/05/328/002 |
Daptomycin | Merck Sharp & Dohme BV | — |
| Delstrigo 100 mg/300 mg/245 mg film-coated tablets EU/1/18/1333/001-002 |
Doravirine, Lamivudine, Tenofovir disoproxil fumarate | Merck Sharp & Dohme BV, | — |
| Efficib 50 mg/1000 mg film-coated tablets EU/1/08/457/8-14 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Efficib 50 mg/850 mg film-coated tablets EU/1/08/457/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV, | — |
| EMEND 125 mg hard capsules EU/1/03/262/004-005 |
Aprepitant | Merck Sharp & Dohme BV, | — |
| EMEND 125 mg hard capsules EMEND 80 mg hard capsules EU/1/03/262/006 |
Aprepitant | Merck Sharp & Dohme BV, | — |
| Emend 125 mg powder for oral suspension EU/1/03/262/011 |
Aprepitant | Merck Sharp & Dohme BV, | — |
| EMEND 80 mg hard capsules EU/1/03/262/001-003 |
Aprepitant | Merck Sharp & Dohme BV, | — |
| Ervebo solution for injection EU/1/19/1392/001 |
Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live Attenuated) | Merck Sharp & Dohme BV, | — |
| Gardasil EU/1/06/357/01-21 |
Quadrivalent human papillomavirus type 11 recombinant vaccine (in), Quadrivalent human papillomavirus type 16 recombinant vaccine (in), Quadrivalent human papillomavirus type 18 recombinant vaccine (in), Quadrivalent human papillomavirus type 6 recombinant vaccine | Merck Sharp & Dohme BV, | — |
| Gardasil 9 suspension for injection. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed) EU/1/15/1007/001-004 |
Hpv type 6 l1 protein, Hpv type 11 l1 protein, Hpv 16 l1 protein, Hpv 18 l1 protein, Hpv type 31 l1 protein | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/002 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/003 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/004 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/005 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/006 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/007 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/008 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/009 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/010 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/011 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/012 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/013 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/014 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/015 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | Marketed |
| HBVAXPRO EU/1/01/183/018-025 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO EU/1/01/183/026-029 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| HBVAXPRO 5 micrograms, suspension for injection EU/1/01/183/001 |
Hepatitis b vaccine | Merck Sharp & Dohme BV, | — |
| Invanz EU/1/02/216/001 |
Ertapenem sodium | Merck Sharp & Dohme BV, | — |
| Isentress 100 mg Chewable tablet EU/1/07/436/004 |
Raltegravir | Merck Sharp & Dohme BV | — |
| Isentress 100 mg Granules for oral suspension EU/1/07/436/005 |
Raltegravir | Merck Sharp & Dohme BV | — |
| Isentress 25 mg Chewable tablet EU/1/07/436/003 |
Raltegravir | Merck Sharp & Dohme BV, | — |
| Isentress 400 mg Film-coated tablet EU/1/07/436/1-2 |
Raltegravir potassium | Merck Sharp & Dohme BV, | — |
| Isentress 600 mg Film-coated tablet EU/1/07/436/006 |
Raltegravir | Merck Sharp & Dohme BV | — |
| Ivemend 150 mg Powder for solution for infusion EU/1/07/437/003-004 |
Fosaprepitant dimeglumine | Merck Sharp & Dohme BV, | — |
| Janumet 50 mg/1000 mg film-coated tablets EU/1/08/455/008-014 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Janumet 50 mg/850 mg film-coated tablets EU/1/08/455/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV, | — |
| Januvia 100 mg film-coated tablets EU/1/07/383/13-18 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Januvia 25 mg film-coated tablets EU/1/07/383/1-6 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV, | — |
| Januvia 50 mg film-coated tablets EU/1/07/383/7-12 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| KEYTRUDA 25 mg/mL concentrate for solution for infusion EU/1/15/1024/002 |
Pembrolizumab | Merck Sharp & Dohme BV, | — |
| LYFNUA 45 mg Film-coated tablet EU/1/21/1613/001-004 |
Gefapixant | Merck Sharp & Dohme BV, | — |
| M-M-RvaxPro powder and solvent for suspension for injection Measles, mumps and rubella vaccine (live) EU/1/06/337/1-13 |
Mumps virus live attenuated jeryl lynn strain, Rubella virus (wistar ra 27/3 strain) live attenuated, Measles virus live attenuated derived from the edmonston b strain | Merck Sharp & Dohme BV, | — |
| Noxafil 100 mg gastro-resistant tablets EU/1/05/320/002-003 |
Posaconazole | Merck Sharp & Dohme BV, | — |
| Noxafil 300 mg concentrate for solution for infusion EU/1/05/320/004 |
Posaconazole | Merck Sharp & Dohme BV, | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.